Valiant Laboratories Ltd

NSE: VALIANTLAB · BSE: 543998 · Pharmaceuticals & Biotechnology · 24 announcements

Share price: ₹124.25
Market cap: ₹674.8 Cr
Revenue (annual): ₹237.5 Cr
Net profit (annual): ₹-3.27 Cr
P/E (TTM): 42.2×Sector 47.4×
Promoter holding: 74.94%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 4 Management Change 3 Financial Results 3 Results Correction 2 Board Meeting Outcome 2 Board Meeting Date 2 Promoter Buying (Off-Market) 1 Merger & Restructuring 1 Legal & Regulatory 1 Fund Raise 1 Credit Rating 1 Annual Report 1 Annual General Meeting 1 Acquisition 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

10 Aug 2026 20:57 IST NSE

Merger & Restructuring

Valiant Laboratories Merger & Restructuring Worth ₹60 Cr

Valiant Laboratories will invest up to ₹60 Crore in its wholly-owned subsidiary, Valiant Advanced Sciences, through preference shares to support its capital base and operations.

Value: ₹60.00 Cr
Execution: 12 months

Read the filing ↗